(Q33366011)

26 July 2017

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme (English)

1 reference

Adaptive radiation therapy

26 July 2017

0 references

0 references

1 reference

O Chinot

11

0 references

author name string

M Barrié

1

1 reference

26 July 2017

C Couprie

2

1 reference

26 July 2017

H Dufour

3

1 reference

26 July 2017

D Figarella-Branger

4

1 reference

26 July 2017

X Muracciole

5

1 reference

26 July 2017

K Hoang-Xuan

6

1 reference

26 July 2017

D Braguer

7

1 reference

26 July 2017

P M Martin

8

1 reference

26 July 2017

J C Peragut

9

1 reference

26 July 2017

F Grisoli

10

1 reference

26 July 2017

27 April 2005

1 reference

26 July 2017

1 reference

26 July 2017

16

1 reference

26 July 2017

7

1 reference

26 July 2017

1177-1184

1 reference

Should radiotherapy be standard therapy for brain tumors in the elderly? Cons.

26 July 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Up-front chemotherapy with fotemustine (F) / cisplatin (CDDP) / etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Survival after stereotactic biopsy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDI225

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDI225

1 reference

26 July 2017

1 reference